Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 16.67%14K | 8.33%13K | 18.18%13K | 4.44%47K | 9.09%12K | 9.09%12K | 0.00%12K | 0.00%11K | 0.00%45K | 0.00%11K |
| Gross profit | -16.67%-14K | -8.33%-13K | -18.18%-13K | -4.44%-47K | -9.09%-12K | -9.09%-12K | 0.00%-12K | 0.00%-11K | 0.00%-45K | 0.00%-11K |
| Operating expense | 943.65%1.32M | -13.44%644K | 1,627.66%812K | 14.97%1.58M | 882.35%665K | -85.76%126K | 294.26%744K | -95.10%47K | -57.67%1.38M | -103.89%-85K |
| Selling and administrative expenses | 1,612.33%1.25M | -6.32%563K | 1,750.00%740K | 58.04%1.31M | 339.11%593K | -87.15%73K | 241.75%601K | -95.70%40K | -73.82%827K | -111.47%-248K |
| -General and administrative expense | 1,612.33%1.25M | -6.32%563K | 1,750.00%740K | 58.04%1.31M | 339.11%593K | -87.15%73K | 241.75%601K | -95.70%40K | -73.82%827K | -111.47%-248K |
| Other operating expenses | 22.64%65K | -43.36%81K | 928.57%72K | -49.91%275K | -55.83%72K | -83.28%53K | 248.78%143K | -75.00%7K | 496.74%549K | 579.17%163K |
| Operating profit | -863.04%-1.33M | 13.10%-657K | -1,322.41%-825K | -14.64%-1.63M | -1,014.86%-677K | 84.60%-138K | -303.77%-756K | 94.02%-58K | 56.89%-1.42M | 103.37%74K |
| Net non-operating interest income (expenses) | -6.21%-941K | -6.27%-932K | -7.70%-909K | -7.37%-3.5M | -7.25%-888K | -7.39%-886K | -7.48%-877K | -7.38%-844K | -6.69%-3.26M | -7.12%-828K |
| Non-operating interest expense | 6.21%941K | 6.27%932K | 7.70%909K | 7.37%3.5M | 7.25%888K | 7.39%886K | 7.48%877K | 7.38%844K | 6.69%3.26M | 7.12%828K |
| Other net income (expenses) | -137.51%-332K | 1,840.34%2.07M | 198.59%841K | -298.56%-2.21M | -293.88%-2.12M | 227.71%885K | -146.48%-119K | -287.47%-853K | 170.51%1.11M | -37.34%1.09M |
| Gain on sale of security | -136.66%-327K | 1,873.50%2.08M | 196.15%824K | -322.47%-2.2M | -316.80%-2.12M | 229.09%892K | -146.06%-117K | -290.87%-857K | 162.65%988K | -51.20%976K |
| Other non-operating income (expenses) | 28.57%-5K | -100.00%-4K | 325.00%17K | -108.06%-10K | -104.24%-5K | -250.00%-7K | -200.00%-2K | -33.33%4K | --124K | --118K |
| Income before tax | -1,771.94%-2.6M | 127.51%482K | 49.12%-893K | -105.72%-7.33M | -1,184.12%-3.69M | 94.24%-139K | -826.98%-1.75M | -34.90%-1.76M | 55.02%-3.56M | 127.76%340K |
| Income tax | 0 | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -1,771.94%-2.6M | 127.51%482K | 49.12%-893K | -105.72%-7.33M | -1,184.12%-3.69M | 94.24%-139K | -826.98%-1.75M | -34.90%-1.76M | 55.02%-3.56M | 127.76%340K |
| Net income continuous operations | -1,771.94%-2.6M | 127.51%482K | 49.12%-893K | -105.72%-7.33M | -1,184.12%-3.69M | 94.24%-139K | -826.98%-1.75M | -34.90%-1.76M | 55.02%-3.56M | 127.76%340K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -1,771.94%-2.6M | 127.51%482K | 49.12%-893K | -105.72%-7.33M | -1,184.12%-3.69M | 94.24%-139K | -826.98%-1.75M | -34.90%-1.76M | 55.02%-3.56M | 127.76%340K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -1,771.94%-2.6M | 127.51%482K | 49.12%-893K | -105.72%-7.33M | -1,184.12%-3.69M | 94.24%-139K | -826.98%-1.75M | -34.90%-1.76M | 55.02%-3.56M | 127.76%340K |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | -2,490.67%-0.01 | 0 | 50.00%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | 0 | -2,490.67%-0.01 | 0 | 50.00%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.